Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Gruppo Oncologico Del Nord-ovest

Clinical trials sponsored by Gruppo Oncologico Del Nord-ovest, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New trial aims to shrink colorectal tumors before surgery with targeted drugs Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 6 Not yet recruiting 2 Not yet finished but already full! 8 Completed 1 Terminated 1

Which drug first? new trial aims to improve survival in tough colorectal cancer

Disease control Completed

This phase 2 trial is testing two different sequences of the drugs panitumumab and regorafenib in 214 patients with advanced colorectal cancer that no longer responds to standard treatments. The goal is to see which order of these drugs helps patients live longer. Participants mu…

Phase 2 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control

Last updated Aug 30, 2026 00:00 UTC